✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹119 Cr.
P/E
0.00

Key Ratios

Market cap
Market cap
119 Cr
PE
PE
-
Prom Holding
Prom Holding
50.30 %
ROE (%)
ROE (%)
-6.68
ROCE (%)
ROCE (%)
1.68
Div Yield (%)
Div Yield (%)
-
Sales
Sales
299 Cr
OPM (%)
OPM (%)
7.74 %
Debt to Equity
Debt to Equity
0.70

About

Mangalam Drugs and Organics Limited is an India-based company engaged in the manufacturing of … Read more
Low
70
52W Range
High
140
  • Mangalam Drugs&Org.
  • Bal Pharma
  • Tyche Inds

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Raw Material Break-Up

Operational Metrics

    Select a Metric
    • Advertisement Spend as a % of Total Sales (%)
    • R&D as a % of Total Sales (%)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Mangalam Drugs And Organics Ltd. Business

    Mangalam Drugs and Organics Limited, an India-based company, specializes in manufacturing various chemicals including active pharma ingredients, perfumery, disperse dye intermediates, bulk drugs, and bulk drugs intermediates.

    Mangalam Drugs&Org. major competitors are Bal Pharma, Tyche Inds, Smruthi Organics, Lasa Supergenerics, Haleos Labs, Nectar Lifesciences, Everest Organics.
    Market Cap of Mangalam Drugs&Org. is ₹119 Crs.
    While the median market cap of its peers are ₹162 Crs.

    Mangalam Drugs&Org. seems to be less financially stable compared to its competitors.
    Altman Z score of Mangalam Drugs&Org. is 2.03 and is ranked 5 out of its 8 competitors.

    Company Filing

    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation Mar Jun Dec
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Mangalam Drugs And Organics Ltd.
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material